These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 27837105)
21. CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells. Cao W; Lee SH; Lu J Biochem J; 2005 Jan; 385(Pt 1):85-93. PubMed ID: 15320871 [TBL] [Abstract][Full Text] [Related]
22. Human T lymphoblasts and activated dendritic cells in the allogeneic mixed leukocyte reaction are susceptible to NK cell-mediated anti-CD83-dependent cytotoxicity. Munster DJ; MacDonald KP; Kato M; Hart DJ Int Immunol; 2004 Jan; 16(1):33-42. PubMed ID: 14688058 [TBL] [Abstract][Full Text] [Related]
23. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation. Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134 [TBL] [Abstract][Full Text] [Related]
24. Differentiation and activation of equine monocyte-derived dendritic cells are not correlated with CD206 or CD83 expression. Moyo NA; Marchi E; Steinbach F Immunology; 2013 Aug; 139(4):472-83. PubMed ID: 23461413 [TBL] [Abstract][Full Text] [Related]
25. Granulocyte-macrophage colony-stimulating factor drives monocytes to CD14low CD83+ DCSIGN- interleukin-10-producing myeloid cells with differential effects on T-cell subsets. Ganguly D; Paul K; Bagchi J; Rakshit S; Mandal L; Bandyopadhyay G; Bandyopadhyay S Immunology; 2007 Aug; 121(4):499-507. PubMed ID: 17433076 [TBL] [Abstract][Full Text] [Related]
26. The CD83 reporter mouse elucidates the activity of the CD83 promoter in B, T, and dendritic cell populations in vivo. Lechmann M; Shuman N; Wakeham A; Mak TW Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11887-92. PubMed ID: 18701714 [TBL] [Abstract][Full Text] [Related]
27. CD83: an update on functions and prospects of the maturation marker of dendritic cells. Prechtel AT; Steinkasserer A Arch Dermatol Res; 2007 May; 299(2):59-69. PubMed ID: 17334966 [TBL] [Abstract][Full Text] [Related]
28. Production and characterization of human soluble CD83 fused with the fragment crystallizable region of human IgG1 in Pichia pastoris. Yuan Y; Wan L; Chen Y; Shi M; Wang C; Zhao J; Lu X; Wang H; Lu Y; Cheng J Appl Microbiol Biotechnol; 2013 Nov; 97(21):9409-17. PubMed ID: 23392767 [TBL] [Abstract][Full Text] [Related]
29. Transgenic expression of a CD83-immunoglobulin fusion protein impairs the development of immune-competent CD4-positive T cells. Lüthje K; Cramer SO; Ehrlich S; Veit A; Steeg C; Fleischer B; Bonin Av; Breloer M Eur J Immunol; 2006 Aug; 36(8):2035-45. PubMed ID: 16841299 [TBL] [Abstract][Full Text] [Related]
31. CD83 on dendritic cells: more than just a marker for maturation. Lechmann M; Berchtold S; Hauber J; Steinkasserer A Trends Immunol; 2002 Jun; 23(6):273-5. PubMed ID: 12072358 [TBL] [Abstract][Full Text] [Related]
32. An increase of CD83+ dendritic cells ex vivo correlates with increased regulatory T cells in patients with active eosinophilic granulomatosis and polyangiitis. Tsurikisawa N; Saito H; Oshikata C; Tsuburai T; Ishiyama M; Mitomi H; Akiyama K BMC Immunol; 2014 Aug; 15():32. PubMed ID: 25174446 [TBL] [Abstract][Full Text] [Related]
33. Epicubenol and Ferruginol induce DC from human monocytes and differentiate IL-10-producing regulatory T cells in vitro. Takei M; Umeyama A; Arihara S Biochem Biophys Res Commun; 2005 Nov; 337(2):730-8. PubMed ID: 16202980 [TBL] [Abstract][Full Text] [Related]
35. CD83: a regulatory molecule of the immune system with great potential for therapeutic application. Fujimoto Y; Tedder TF J Med Dent Sci; 2006 Jun; 53(2):85-91. PubMed ID: 16913569 [TBL] [Abstract][Full Text] [Related]